Investment area

Growth Investments

Bioindustrial Investments


North America

Date of investment

June 2021

Genomatica is harnessing biology to remake everyday products and materials built by and for the planet. The Company is developing and scaling sustainable materials derived from plant- or waste-based feedstocks instead of fossil fuels to help brands deliver on their climate goals and our planet’s needs.

Visit site


Kartik Dharmadhikari


Departments: Growth Investments, Novo Holdings Equity US Inc., Bioindustrial Investments

Kartik focuses on investments across industrial biotechnology and is based in our San Francisco office.

Prior to joining Novo Holdings, Kartik served as Associate Partner at McKinsey & Co. working with clients across healthcare, agriculture, chemicals and consumer products on biotechnology strategy and operational topics. Previous to that, Kartik worked at Novozymes in a variety of business building and corporate development roles in both Denmark and the U.S.

Kartik holds an MBA from Columbia Business School and a BA from Northwestern University.